Cita APA (7a ed.)
Chimonas, S., Cosenza, C., Kesselheim, A. S., Toyserkani, G. A., Oswell, K. H., LaCivita, C., . . . Sarpatwari, A. (2026). Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials. Drug Safety, 49(6), 667-676.
Cita Chicago Style (17a ed.)
Chimonas, Susan, Carol Cosenza, Aaron S. Kesselheim, Gita A. Toyserkani, Kate Heinrich Oswell, Cynthia LaCivita, Gerald J. Dal Pan, y Ameet Sarpatwari. "Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials." Drug Safety 49, no. 6 (2026): 667-676.
Cita MLA (9a ed.)
Chimonas, Susan, et al. "Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials." Drug Safety, vol. 49, no. 6, 2026, pp. 667-676.
Precaución: Estas citas no son 100% exactas.